###begin article-title 0
Critical Role of Activating Transcription Factor 4 in the Anabolic Actions of Parathyroid Hormone in Bone
###end article-title 0
###begin p 1
Conceived and designed the experiments: SY JF JZ DR GX. Performed the experiments: SY ML DJ HC TGK YL KP KH GX. Analyzed the data: SY RF TGK DR GX. Wrote the paper: RF GX.
###end p 1
###begin p 2
###xml 295 299 <span type="species:ncbi:10090">mice</span>
Parathyroid hormone (PTH) is a potent anabolic agent for the treatment of osteoporosis. However, its mechanism of action in osteoblast and bone is not well understood. In this study, we show that the anabolic actions of PTH in bone are severely impaired in both growing and adult ovariectomized mice lacking bone-related activating transcription factor 4 (ATF4). Our study demonstrates that ATF4 deficiency suppresses PTH-stimulated osteoblast proliferation and survival and abolishes PTH-induced osteoblast differentiation, which, together, compromise the anabolic response. We further demonstrate that the PTH-dependent increase in osteoblast differentiation is correlated with ATF4-dependent up-regulation of Osterix. This regulation involves interactions of ATF4 with a specific enhancer sequence in the Osterix promoter. Furthermore, actions of PTH on Osterix require this same element and are associated with increased binding of ATF4 to chromatin. Taken together these experiments establish a fundamental role for ATF4 in the anabolic actions of PTH on the skeleton.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 302 305 302 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Neer1">[1]</xref>
###xml 306 309 306 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Jilka1">[6]</xref>
###xml 667 670 667 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Miyakoshi1">[7]</xref>
###xml 672 675 672 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Hurley1">[8]</xref>
###xml 804 807 804 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Partridge1">[9]</xref>
###xml 809 813 809 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-McCauley1">[10]</xref>
###xml 954 956 954 956 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 982 986 982 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Swarthout1">[11]</xref>
###xml 1079 1083 1079 1083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Carpio1">[12]</xref>
###xml 1085 1089 1085 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Swarthout2">[13]</xref>
###xml 1310 1313 1310 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Miao1">[2]</xref>
###xml 1315 1319 1315 1319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Calvi1">[14]</xref>
###xml 1321 1325 1321 1325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Datta1">[15]</xref>
###xml 1364 1367 1364 1367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Jilka1">[6]</xref>
###xml 1369 1373 1369 1373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Bellido1">[16]</xref>
###xml 1375 1379 1375 1379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Chen1">[17]</xref>
Parathyroid hormone (PTH) is a major regulator of calcium homeostasis and has both catabolic and anabolic effects on osteoblasts and bone that depend on the temporal pattern of administration. Continuous administration of PTH decreases bone mass whereas intermittent administration increases bone mass [1]-[6]. The mechanism(s) responsible for these differing effects are poorly understood. The anabolic activity of PTH has been attributed to both direct actions of this hormone on osteoprogenitor cells as well as indirect effects mediated by the production of growth factors such as insulin-like growth factor-1 (IGF-1) and basic fibroblast growth factor-2 (FGF-2) [7], [8]. Most cellular actions of PTH are mediated by the PTH-1 receptor, a G protein-coupled receptor that is expressed in osteoblasts [9], [10]. Binding of PTH to its receptor activates multiple intracellular signaling pathways that involve cAMP, inositol phosphates, intracellular Ca2+, protein kinases A and C [11], and the extracellular signal-related (ERK)/mitogen-activated protein kinase (MAPK) pathway [12], [13]. Activation of these signal transduction pathways ultimately affects cellular behavior. In this regard, the anabolic actions of PTH on bone have been attributed to increased proliferation of osteopregenitors/osteoblasts [2], [14], [15] and/or decreased osteoblast apoptosis [6], [16], [17].
###end p 4
###begin p 5
###xml 98 102 98 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Pearman1">[18]</xref>
###xml 104 108 104 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Gonzalez1">[19]</xref>
###xml 129 133 129 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Selvamurugan1">[20]</xref>
###xml 134 138 134 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-McCauley3">[22]</xref>
###xml 150 154 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Selvamurugan1">[20]</xref>
###xml 156 160 156 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Krishnan1">[23]</xref>
###xml 521 532 521 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">osteocalcin</italic>
###xml 534 537 534 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ocn</italic>
###xml 746 749 746 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ocn</italic>
###xml 766 770 766 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Ducy1">[24]</xref>
###xml 771 775 771 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Banerjee2">[28]</xref>
###xml 789 792 789 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ocn</italic>
###xml 818 822 818 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Boudreaux1">[29]</xref>
###xml 824 828 824 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Yu1">[30]</xref>
###xml 1014 1018 1014 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mOG2</italic>
###xml 1028 1032 1028 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Ducy1">[24]</xref>
###xml 1092 1096 1092 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Jiang1">[31]</xref>
###xml 1316 1320 1316 1320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4</italic>
###xml 1336 1340 1336 1340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Yang1">[26]</xref>
###xml 1455 1459 1455 1459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Yang2">[32]</xref>
###xml 1461 1465 1461 1465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Zhang1">[33]</xref>
###xml 1534 1537 1534 1537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ocn</italic>
###xml 1564 1568 1564 1568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Yu2">[34]</xref>
###xml 1740 1743 1740 1743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ocn</italic>
###xml 1860 1863 1860 1863 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1856 1863 1856 1863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 1331 1335 <span type="species:ncbi:10090">mice</span>
###xml 1864 1868 <span type="species:ncbi:10090">mice</span>
Although a number of transcription factors including cAMP response element binding protein (CREB) [18], [19], AP1 family members [20]-[22], and Runx2 [20], [23] have been implicated in the molecular actions of PTH in osteoblasts, genetic studies have not strongly linked any of these factors in the anabolic actions of this hormone. To better understand the anabolic actions of PTH, it is essential that the downstream signals induced by this hormone be identified and evaluated for possible roles in bone formation. The osteocalcin (Ocn) promoter has been an important tool for unraveling the mechanisms mediating osteoblast-specific gene expression and was used to identify a number of important transcription factors and cofactors involved in Ocn gene expression [24]-[28]. Because the Ocn gene is regulated by PTH [29], [30], we have used it as a model system for identifying new transcriptional mediators of PTH action. We previously demonstrated that the OSE1 (osteoblast-specific element 1) in the proximal mOG2 promoter [24] is necessary and sufficient for PTH induction of this gene [31]. The OSE1 core sequence (TTACATCA) was subsequently identified as a DNA binding site for the ATF4 transcription factor. The critical role of ATF4 in osteoblast differentiation and bone development was established using Atf4-deficient mice [26]. At the cellular level, ATF4 is critical for proliferation and differentiation as well as survival in osteoblasts [32], [33]. We recently showed that ATF4 is also required for PTH induction of Ocn expression in osteoblasts [34]. Specifically, PTH elevated levels of ATF4 mRNA and protein in a dose and time-dependent manner and increased binding of ATF4 to OSE1 DNA. Furthermore, PTH stimulation of Ocn expression was lost by siRNA downregulation of ATF4 in MC-4 cells and in primary bone marrow stromal cells from Atf4-/- mice. Collectively, these studies demonstrate that ATF4 is a novel downstream mediator of PTH signaling.
###end p 5
###begin p 6
###xml 150 154 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Nakashima1">[35]</xref>
###xml 204 208 204 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Nakashima1">[35]</xref>
###xml 259 263 259 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Ducy2">[25]</xref>
###xml 265 269 265 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Otto1">[36]</xref>
###xml 270 274 270 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Komori1">[38]</xref>
###xml 185 189 <span type="species:ncbi:10090">mice</span>
Osterix (Osx, or Sp7), a zinc-finger-containing transcription factor of the sp family, is essential for osteoblast differentiation and bone formation [35]. Since Osx is not detected in mice lacking Runx2 [35], a master regulator of osteoblast differentiation [25], [36]-[38], it functions downstream of Runx2. However, the molecular mechanisms whereby the Osx gene is transcriptionally regulated are not well understood.
###end p 6
###begin p 7
###xml 45 49 <span type="species:ncbi:10090">mice</span>
In the present study, we used ATF4-deficient mice to determine whether ATF4 is more generally required for the in vivo anabolic actions of PTH in bone as well as explore the mechanism used by PTH to regulate ATF4 activity. As will be shown, loss of ATF4 greatly attenuated the anabolic effects of PTH. Furthermore, ATF4 may participate in the PTH response by regulating the expression of the Osterix transcription factor.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
###xml 84 88 <span type="species:ncbi:10090">mice</span>
The anabolic effects of PTH on bone are severely impaired in growing Atf4-deficient mice
###end title 9
###begin p 10
###xml 244 247 244 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Miao1">[2]</xref>
###xml 248 251 248 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-IidaKlein1">[4]</xref>
###xml 253 256 253 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Hurley1">[8]</xref>
###xml 258 262 258 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Hock1">[39]</xref>
###xml 264 268 264 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Tanaka1">[40]</xref>
###xml 515 518 515 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Miao1">[2]</xref>
###xml 520 524 520 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Swarthout1">[11]</xref>
###xml 526 530 526 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Calvi1">[14]</xref>
###xml 532 536 532 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Bellido1">[16]</xref>
###xml 537 541 537 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Pearman1">[18]</xref>
###xml 543 547 543 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Cole1">[41]</xref>
###xml 548 552 548 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Calvi2">[43]</xref>
###xml 765 768 765 768 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 761 768 761 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 926 929 926 929 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 922 929 922 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 939 947 939 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007583.s001">Fig. S1A</xref>
###xml 954 957 954 957 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 950 957 950 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 988 990 988 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</italic>
###xml 998 1001 998 1001 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 994 1001 994 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>+/&#8722;</sup></italic>
###xml 1056 1059 1056 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Demiralp1">[3]</xref>
###xml 1101 1109 1101 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007583.s001">Fig. S1B</xref>
###xml 1194 1197 1194 1197 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1190 1197 1190 1197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>+/&#8722;</sup></italic>
###xml 1213 1216 1213 1216 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1209 1216 1209 1216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 1223 1231 1223 1231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007583.s001">Fig. S1C</xref>
###xml 1270 1284 1270 1284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007583.s001">Fig. S1D and E</xref>
###xml 1388 1390 1388 1390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</italic>
###xml 1399 1402 1399 1402 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1395 1402 1395 1402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>+/&#8722;</sup></italic>
###xml 1548 1555 1548 1555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007583.s002">Fig. S2</xref>
###xml 1657 1660 1657 1660 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1653 1660 1653 1660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 1669 1676 1669 1676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007583.s002">Fig. S2</xref>
###xml 1699 1705 1699 1705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g001">Fig. 1</xref>
###xml 1788 1791 1787 1790 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1784 1791 1783 1790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 1990 1992 1989 1991 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</italic>
###xml 2000 2003 1999 2002 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1996 2003 1995 2002 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>+/&#8722;</sup></italic>
###xml 2127 2131 2126 2130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Yang1">[26]</xref>
###xml 2149 2151 2148 2150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</italic>
###xml 2334 2337 2333 2336 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 2330 2337 2329 2336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>+/&#8722;</sup></italic>
###xml 2344 2351 2343 2350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g001">Fig. 1B</xref>
###xml 2414 2417 2413 2416 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2410 2417 2409 2416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 2685 2688 2684 2687 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2681 2688 2680 2687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 2706 2708 2705 2707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</italic>
###xml 2716 2719 2715 2718 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 2712 2719 2711 2718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>+/&#8722;</sup></italic>
###xml 2761 2764 2760 2763 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2757 2764 2756 2763 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 2854 2857 2853 2856 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2850 2857 2849 2856 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 2943 2946 2942 2945 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 2939 2946 2938 2945 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>+/+</sup></italic>
###xml 2955 2958 2954 2957 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 2951 2958 2950 2957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>+/&#8722;</sup></italic>
###xml 3034 3036 3033 3035 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</italic>
###xml 3045 3048 3044 3047 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 3041 3048 3040 3047 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 124 129 <span type="species:ncbi:10090">mouse</span>
###xml 373 378 <span type="species:ncbi:10090">mouse</span>
###xml 554 558 <span type="species:ncbi:10090">Mice</span>
###xml 697 701 <span type="species:ncbi:10090">mice</span>
###xml 769 773 <span type="species:ncbi:10090">mice</span>
###xml 1217 1221 <span type="species:ncbi:10090">mice</span>
###xml 1403 1407 <span type="species:ncbi:10090">mice</span>
###xml 1792 1796 <span type="species:ncbi:10090">mice</span>
###xml 2338 2342 <span type="species:ncbi:10090">mice</span>
###xml 2418 2422 <span type="species:ncbi:10090">mice</span>
###xml 2689 2693 <span type="species:ncbi:10090">mice</span>
###xml 2720 2724 <span type="species:ncbi:10090">mice</span>
###xml 2959 2963 <span type="species:ncbi:10090">mice</span>
###xml 3049 3053 <span type="species:ncbi:10090">mice</span>
We first evaluated our hypothesis that ATF4 mediates the anabolic actions of PTH in bone using a relatively simple "growing mouse" model system, that has been widely used for studying the anabolic actions of PTH, PTHrP, FGF2, and IGF-1 in bone [2]-[4], [8], [39], [40]. The advantages of this system are that it is less time consuming and costly versus adult ovarectomized mouse models. Furthermore, because young growing animals have relatively high osteoblast activity, they are more sensitive to PTH than adults [2], [11], [14], [16]-[18], [41]-[43]. Mice were treated with vehicle or PTH and sacrificed 24 h after the last PTH injection. PTH-dependent anabolic activity was evaluated in these mice using standard biochemical and histomorphometric criteria. Atf4-/- mice grew more slowly than wild type (wt) animals. The growth rate was slightly but significantly increased by PTH treatment during d 6-18 in wt but not Atf4-/- animals (Fig. S1A). Atf4-/- femurs were also shorter than wt or Atf4+/- femurs. Consistent with results from a previous study [3], PTH did not alter the length of femurs (Fig. S1B). However, it did significantly increase the dry ash weight per femur in wt and Atf4+/- but not in Atf4-/- mice (Fig. S1C). Serum Pi and calcium concentration (Fig. S1D and E) were not markedly affected by PTH or ATF4 deficiency. Faxitron X-ray analysis of femurs revealed that wt and Atf4+/- mice responded to PTH with markedly increased radiopacity throughout the whole femur, with the most dramatic increase in the metaphyseal region (Fig. S2, top and middle). In contrast, PTH only slightly increased the radiopacity in the same region of Atf4-/- femurs (Fig. S2, bottom). As shown in Fig. 1, quantitative muCT analysis of femur histomorphometric parameters showed that Atf4-/- mice had a significant reduction in bone volume/tissue volume (BV/TV), trabecular number (Tb.N), and cortical thickness (Cort.Th) and a marked increase in trabecular space (Tb.Sp) compared with the wt or Atf4+/- littermates. These data confirmed an essential role of ATF4 in bone that was previously demonstrated by the Karsenty group [26]. As expected, in wt femurs, intermittent PTH increased BV/TV, Tb.N, and Tb.Th by 5.4-fold, 2.7-fold, and 1.5-fold, respectively, and decreased Tb.Sp by 60 percent. Similar effects were also seen in Atf4+/- mice (Fig. 1B). In contrast, the PTH response was greatly attenuated in Atf4-/- mice where the following PTH responses were observed; BV/TV, 2.2-fold increase; Tb.N, 1.7-fold increase; Tb.Th, 1.1-fold increase; Tb.Sp, 36 percent decrease. In all cases, the magnitude of PTH-stimulated changes on BV/TV, Tb.N, Tb.Sp was dramatically reduced in Atf4-/- mice relative to wt or Atf4+/- mice (P<0.05, PTH/veh-wt vs. PTH/veh-Atf4-/-). Furthermore, PTH-stimulated increases in Cort.Th and Tb.Th were completely lost in Atf4-/- femurs. Because PTH similarly affected all trabecular and cortical parameters in Atf4+/+ and Atf4+/- mice, subsequent experiments compared the PTH effects on bone only between wt and Atf4-/- mice.
###end p 10
###begin title 11
###xml 61 64 61 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
PTH-stimulated bone was significantly reduced or lost in Atf4-/- femurs.
###end title 11
###begin p 12
###xml 77 79 76 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</italic>
###xml 85 88 84 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 81 88 80 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>+/&#8722;</sup></italic>
###xml 97 100 96 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 93 100 92 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 361 368 360 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> &#8224;</sup>
###xml 392 395 386 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 388 395 382 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 402 403 396 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 438 441 432 435 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 434 441 428 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
A, two-dimensional (2D) reconstruction from muCT scan of femurs from growing wt, Atf4+/- and Atf4-/- mice treated with and without intermittent PTH for 28 d. B, quantitative analysis of bone volume/tissue volume (BV/TV), trabecular number (Tb. N), trabecular thickness (Tb.Th), trabecular space (Tb.Sp), and cortical thickness (Cort. Th). *P<0.05 (veh vs. PTH), dagger P<0.05 (wt-veh vs. Atf4-/--veh), #P<0.05 (PTH/veh-wt vs. PTH/veh-Atf4-/-).
###end p 12
###begin p 13
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4</italic>
###xml 238 251 238 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g002">Fig. 2A and B</xref>
###xml 257 261 257 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4</italic>
###xml 261 264 261 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 423 426 423 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 419 426 419 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 463 466 463 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 459 466 459 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 468 477 468 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g002">Fig. 2C-E</xref>
###xml 578 582 578 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4</italic>
###xml 582 585 582 585 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 623 626 623 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 619 626 619 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 664 667 664 667 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 660 667 660 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 669 678 669 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g002">Fig. 2F&#8211;J</xref>
###xml 792 794 792 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</italic>
###xml 834 838 834 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4</italic>
###xml 838 841 838 841 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 851 860 851 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g002">Fig. 2K&#8211;O</xref>
###xml 586 590 <span type="species:ncbi:10090">mice</span>
###xml 795 799 <span type="species:ncbi:10090">mice</span>
We next measured effects of Atf4 gene ablation on PTH stimulation of tibiae, vertebrae, and calvariae. The anabolic effect of PTH on wt tibiae was so dramatic that the majority of the bone marrow cavity was replaced by newly formed bone (Fig. 2A and B). In Atf4-/- tibiae, while PTH still induced a small increase in trabecular area, the magnitude of stimulation was significantly reduced (5-fold in wt vs. 2.2-fold in Atf4-/-)(P<0.05, PTH/veh-wt vs. PTH/veh-Atf4-/-)(Fig. 2C-E). Likewise, the PTH-stimulated increase in the trabeculae of vertebrae (L5) was markedly reduced in Atf4-/- mice (3-fold in wt vs. 2-fold in Atf4-/-) (P<0.05, PTH/veh-wt vs. PTH/veh-Atf4-/-)(Fig. 2F-J). When histological sections of calvariae were compared, PTH increased the width of the calvariae by 1.8-fold in wt mice, a response that was abolished in Atf4-/- animals (Fig. 2K-O).
###end p 13
###begin title 14
###xml 48 51 48 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
PTH-stimulated bone is severely impaired in Atf4-/- tibiae, vertebrae, and calvariae.
###end title 14
###begin p 15
###xml 385 392 385 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> &#8224;</sup>
###xml 416 419 411 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 412 419 407 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 426 427 421 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 462 465 457 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 458 465 453 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
Representative H&E stained sections of tibiae (A-E), vertebrae (L5) (F-J), and calvariae (K-O) are shown. Trabecular bone area versus total area of tibiae (E) and vertebrae (J) was measured using an Image Pro Plus 6.2 software. The calvarial width was obtained from 20 random measurements throughout the whole calvaria using a SPOT Advanced imaging software (O). *P<0.05 (veh vs. PTH), dagger P<0.05 (wt-veh vs. Atf4-/--veh), #P<0.05 (PTH/veh-wt vs. PTH/veh-Atf4-/-).
###end p 15
###begin title 16
###xml 123 127 <span type="species:ncbi:10090">mice</span>
Ablation of the Atf4 gene impairs PTH stimulation of trabecular, but not cortical bone in 7-month-old ovariectomized (OVX) mice
###end title 16
###begin p 17
###xml 1049 1056 1049 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007583.s003">Fig. S3</xref>
###xml 1138 1142 1138 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Mosekilde1">[44]</xref>
###xml 1223 1226 1223 1226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1219 1226 1219 1226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 1248 1251 1248 1251 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1244 1251 1244 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 1266 1269 1266 1269 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1262 1269 1262 1269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 1289 1295 1289 1295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g003">Fig. 3</xref>
###xml 1355 1359 1355 1359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4</italic>
###xml 1496 1499 1496 1499 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1492 1499 1492 1499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 1665 1668 1665 1668 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1661 1668 1661 1668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 1752 1755 1752 1755 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1748 1755 1748 1755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 1884 1887 1884 1887 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1880 1887 1880 1887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 1974 1978 1974 1978 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4</italic>
###xml 2050 2053 2046 2049 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2046 2053 2042 2049 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 2073 2076 2069 2072 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2069 2076 2065 2072 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 2188 2195 2184 2191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g001">Figs. 1</xref>
###xml 2200 2201 2196 2197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g003">3</xref>
###xml 2304 2307 2300 2303 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2300 2307 2296 2303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 2349 2352 2345 2348 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2345 2352 2341 2348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 2389 2392 2385 2388 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2385 2392 2381 2388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 2407 2420 2403 2416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g003">Fig. 3D and E</xref>
###xml 2489 2492 2485 2488 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2485 2492 2481 2488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 2693 2696 2689 2692 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2689 2696 2685 2692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 164 168 <span type="species:ncbi:10090">mice</span>
###xml 486 490 <span type="species:ncbi:10090">mice</span>
###xml 589 594 <span type="species:ncbi:10090">mouse</span>
###xml 822 826 <span type="species:ncbi:10090">mice</span>
###xml 1133 1137 <span type="species:ncbi:10116">rats</span>
###xml 1333 1337 <span type="species:ncbi:10090">mice</span>
###xml 1437 1441 <span type="species:ncbi:10090">mice</span>
###xml 1486 1490 <span type="species:ncbi:10090">mice</span>
###xml 1613 1617 <span type="species:ncbi:10090">mice</span>
###xml 1925 1929 <span type="species:ncbi:10090">mice</span>
###xml 1997 2001 <span type="species:ncbi:10090">mice</span>
###xml 2149 2153 <span type="species:ncbi:10090">mice</span>
###xml 2176 2180 <span type="species:ncbi:10090">mice</span>
The experiments described above clearly establish a critical role of ATF4 in the anabolic effects of PTH on long bones, vertebrae, and calvariae in rapidly growing mice. However, it is possible that results obtained from growing animals may be different from those in adults due to possible effects of PTH and/or ATF4 on animal growth or influences of animal growth on the anabolic response to PTH, either of which could complicate the interpretation of the results. In contrast, adult mice have a mature skeleton in which these possible complications can be avoided. Furthermore, the OVX mouse provides a model that may be more relevant to the clinical applications of PTH in the treatment of osteoporosis. For these reasons, we next evaluated whether ATF4 is required for the anabolic response to PTH in 7-month-old OVX mice. OVX surgery was successful as demonstrated by significant reduction in BV/TV (65 percent), Tb.N (27 percent), and Tb.Th (18 percent) and increased Tb.Sp (37 percent) relative to sham surgery (P<0.05, wt-sham vs. wt-OVX) (Fig. S3). OVX surgery did not reduce Cort.Th, which is consistent with results from rats [44], Interestingly, OVX surgery did not significantly reduce bone parameters in Atf4-/- animals (P>0.05, Atf4-/- -sham vs. Atf4-/- -OVX). As shown in Fig. 3 A-C, similar to results from growing mice, ablation of the Atf4 gene significantly decreased BV/TV and Tb.N and increased Tb.Sp in adult OVX mice. In further agreement with results in young mice, Atf4-/- animals exhibited a clearly attenuated response to PTH. For example, while PTH increased BV/TV by 7.8-fold in wt mice, this value was only increased 4.2-fold in Atf4-/- animals. Similarly, while PTH still stimulated formation of trabecular bone in Atf4-/-trabeculae, the magnitude of this response was significantly reduced compared to wt control (P<0.05, PTH/veh-wt vs. PTH/veh- Atf4-/-). In contrast to result from growing mice, Cort.Th was not reduced by ablation of the Atf4 gene in adult OVX mice (0.21+/-0.01 mm in wt vs. 0.19+/-0.02 mm in Atf4-/-, P>0.05 wt vs. Atf4-/-). Also, PTH was much less effective in stimulating Cort.Th in adult OVX mice (24%) than in growing mice (95%) (Figs. 1 and 3). Furthermore, no difference in stimulation of cortical thickness by PTH was observed when wt and Atf4-/- groups were compared (24% wt vs. 21% Atf4-/-)(P>0.05, PTH/veh-wt vs. PTH/veh-Atf4-/-). As shown in Fig. 3D and E, results from calcein double labeling of 7-month old OVX wt and Atf4-/- tibia revealed that the PTH-stimulated increase in mineral apposition rate (MAR), an indicator of osteoblast function, was significantly reduced by ATF4 deficiency (P<0.05, PTH/veh-wt vs. PTH/veh-Atf4-/-).
###end p 17
###begin title 18
Effects of ATF4 deficiency on PTH stimulation in adult OVX bone.
###end title 18
###begin p 19
###xml 323 330 322 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> &#8224;</sup>
###xml 354 357 348 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 350 357 344 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 364 365 358 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 400 403 394 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 396 403 390 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
A, three-dimensional (3D) reconstruction from muCT scan of distal femurs of adult OVX mice. B, sagittal view of 2D distal femur at 1.7-2.0 mm from the chondro-osseous junction. C, BV/TV, Tb. N, Tb.Th, Tb.Sp, and Cort.Th. D, calcein double labeling of metaphyseal trabecular bone (magnification,x200). *P<0.05 (veh vs. PTH), dagger P<0.05 (wt-veh vs. Atf4-/--veh), #P<0.05 (PTH/veh-wt vs. PTH/veh-Atf4-/-).
###end p 19
###begin title 20
ATF4 deficiency significantly reduces basal and PTH-stimulated proliferation in osteoblasts/preosteoblasts
###end title 20
###begin p 21
###xml 86 90 86 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Calvi1">[14]</xref>
###xml 92 96 92 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Datta1">[15]</xref>
###xml 98 102 98 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Chen1">[17]</xref>
###xml 104 108 104 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Miao2">[45]</xref>
###xml 218 222 218 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Zhang1">[33]</xref>
###xml 224 228 224 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Yu2">[34]</xref>
###xml 361 365 361 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4</italic>
###xml 365 368 365 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 512 529 512 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g004">Fig. 4A, B, and E</xref>
###xml 702 706 702 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4</italic>
###xml 849 858 849 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g004">Fig. 4C&#8211;E</xref>
###xml 985 994 985 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g004">Fig. 4F&#8211;J</xref>
###xml 369 373 <span type="species:ncbi:10090">mice</span>
###xml 537 541 <span type="species:ncbi:10090">mice</span>
PTH and PTHrP are both known to increase the proliferation and numbers of osteoblasts [14], [15], [17], [45]. ATF4 is also a positive regulator of osteoblast proliferation and can be up-regulated by PTH in these cells [33], [34]. To determine whether ATF4 plays a role in PTH regulation of osteoblast proliferation, sections of tibiae and calvariae from wt and Atf4-/- mice treated with and without intermittent PTH were analyzed for in vivo cell proliferation using a Zymed BrdU immunostaining kit. As shown in Fig. 4A, B, and E, in wt mice, PTH increased the percentage of proliferating osteoblasts/preosteoblasts of tibial trabeculae by 2.8-fold relative to vehicle-treated control. Ablation of the Atf4 gene resulted in a 50% decline in basal proliferation. In addition, the PTH-stimulated increase in proliferation was decreased by 40 percent (Fig. 4C-E). Similarly, PTH-induced proliferation in calvarial periosteal osteoblasts was also significantly reduced by ATF4 deficiency (Fig. 4F-J). As expected, very few osteocytes were BrdU-positive in both tibiae and calvariae. Note: basal proliferation rate of calvarial periosteal osteoblasts was significantly higher than that of tibial trabecular osteoblasts (28% vs. 4%). Therefore, ATF4 is critical for basal and PTH-stimulated proliferation of osteoblasts/preosteoblasts in vivo.
###end p 21
###begin title 22
###xml 70 73 70 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
Effects of PTH on osteoblast proliferation and survival in wt and Atf4-/- bone.
###end title 22
###begin p 23
###xml 457 464 457 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Situ</italic>
###xml 795 802 795 797 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> &#8224;</sup>
###xml 826 829 821 824 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 822 829 817 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 836 837 831 832 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 872 875 867 870 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 868 875 863 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
A-J, BrdU staining, sections of tibiae (A-D) and calvariae (F-I) were stained using a Zymed BrdU immunostaining kit. Proliferating cells were stained brown (arrows) and non-proliferating cells were stained blue. Proliferating cells on tibial trabecular surface or osteoid (E) or calvarial periosteal surface (J) were counted and normalized to total cells from the same area. K-P, TUNEL staining, sections of tibiae were stained using the ApopTag Peroxidase In Situ Apoptosis Detection Kit. Apoptotic osteoblasts and osteocytes (arrows) were stained brown and non-apoptotic cells were stained blue. Apoptotic osteoblasts and osteocytes in the trabecular (O) and cortical bone (P) of tibiae were counted and normalized to total osteoblasts and osteocytes from the same area. *P<0.05 (veh vs. PTH), dagger P<0.05 (wt-veh vs. Atf4-/--veh), #P<0.05 (PTH/veh-wt vs. PTH/veh-Atf4-/-).
###end p 23
###begin title 24
###xml 43 46 43 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
PTH fails to reduce apoptotic death in Atf4-/- osteoblasts/osteocytes
###end title 24
###begin p 25
###xml 253 256 253 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Jilka1">[6]</xref>
###xml 258 262 258 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Bellido1">[16]</xref>
###xml 264 268 264 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Chen1">[17]</xref>
###xml 270 274 270 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Miao2">[45]</xref>
###xml 342 346 342 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Zhang1">[33]</xref>
###xml 509 522 509 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g004">Fig. 4K and L</xref>
###xml 763 766 763 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Jilka1">[6]</xref>
###xml 768 772 768 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Bellido1">[16]</xref>
###xml 774 778 774 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Chen1">[17]</xref>
###xml 780 784 780 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Miao2">[45]</xref>
###xml 878 881 878 881 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 874 881 874 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 894 903 894 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g004">Fig. 4M&#8211;O</xref>
###xml 997 1004 997 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g004">Fig. 4P</xref>
Mature osteoblasts synthesize and deposit a mineralizing extracellular matrix and become osteocytes. Both osteoblasts and osteocytes can be lost through apoptosis. PTH signaling increases the survival of osteoblasts and osteocytes by reducing apoptosis [6], [16], [17], [45]. Our recent study shows that ATF4 is anti-apoptotic in osteoblasts [33]. To determine whether ATF4 plays a role in PTH-mediated anti-apoptosis, sections of tibiae were stained with TUNEL and apoptotic cells were assessed. As shown in Fig. 4K and L, ATF4 deficiency significantly increased the basal levels of apoptosis. As expected, PTH dramatically reduced apoptotic death of tibial trabecular osteoblasts/osteocytes by 48 percent, which is consistent with results from previous studies [6], [16], [17], [45]. Importantly, the PTH-stimulated decrease in apoptotic death was completely abolished in Atf4-/- trabeculae (Fig. 4M-O). ATF4 was similarly required for PTH to inhibit apoptosis in cortical osteocytes of tibiae (Fig. 4P). Collectively, ATF4 is essential for PTH-mediated inhibition of apoptosis in osteoblasts/osteocytes in vivo.
###end p 25
###begin title 26
###xml 133 136 133 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
PTH-induced increase in expression of osteoblast differentiation marker genes is dramatically reduced or completely abolished in Atf4-/- animals
###end title 26
###begin p 27
###xml 152 154 152 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</italic>
###xml 159 163 159 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4</italic>
###xml 163 166 163 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 341 348 341 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g005">Fig. 5A</xref>
###xml 465 476 465 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">osteocalcin</italic>
###xml 478 481 478 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ocn</italic>
###xml 495 512 495 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bone sialoprotein</italic>
###xml 514 517 514 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bsp</italic>
###xml 531 551 531 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">alkaline phosphatase</italic>
###xml 553 556 553 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alp</italic>
###xml 570 588 570 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;1(I) collagen</italic>
###xml 590 597 586 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col1(I)</italic>
###xml 610 621 606 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">osteopontin</italic>
###xml 623 626 619 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Opn</italic>
###xml 644 651 640 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">osterix</italic>
###xml 653 656 649 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Osx</italic>
###xml 766 769 762 765 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 762 769 758 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 813 816 809 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ocn</italic>
###xml 821 824 817 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Osx</italic>
###xml 874 878 870 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Yu2">[34]</xref>
###xml 894 898 890 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4</italic>
###xml 933 937 929 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4</italic>
###xml 962 965 958 961 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 958 965 954 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 1079 1082 1075 1078 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1075 1082 1071 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 1103 1110 1099 1106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g005">Fig. 5B</xref>
###xml 1213 1216 1209 1212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Miyakoshi1">[7]</xref>
###xml 1218 1221 1214 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Hurley1">[8]</xref>
###xml 1263 1266 1259 1262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1259 1266 1255 1262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 1312 1315 1308 1311 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1308 1315 1304 1311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 1427 1430 1423 1426 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1423 1430 1419 1426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 167 171 <span type="species:ncbi:10090">mice</span>
###xml 1267 1271 <span type="species:ncbi:10090">mice</span>
###xml 1287 1291 <span type="species:ncbi:10090">mice</span>
We next determined the effects of ATF4 deficiency on PTH induction of osteoblast differentiation markers in vivo. Total RNA was isolated from tibiae of wt and Atf4-/- mice treated with and without PTH for 28 d and expression levels of osteoblast differentiation marker genes were measured by quantitative real-time PCR analysis. As shown in Fig. 5A, PTH dramatically elevated the expression of genes known to be associated with osteoblast differentiation including osteocalcin (Ocn) (2.2-fold), bone sialoprotein (Bsp) (4.2-fold), alkaline phosphatase (Alp) (3.2-fold), alpha1(I) collagen (Col1(I))(4.7-fold), osteopontin (Opn) (4.6-fold), and osterix (Osx) (4.1-fold). Importantly, this PTH regulation was either dramatically reduced or completely abolished in Atf4-/- tibiae. ATF4 deficiency also reduced basal Ocn and Osx mRNA levels. Consistent with our previous report [34], PTH increased Atf4 mRNA 2.2-fold in wt tibiae, while Atf4 was undetectable in Atf4-/- animals. In contrast, c-Fos and c-Jun, both early PTH-induced genes, were not induced by PTH in either wt or Atf4-/- tibiae. As shown in Fig. 5B, the levels of IGF-1 and FGF-2 which have both been implicated in the anabolic actions of PTH in bone [7], [8] were markedly reduced in plasma from Atf4-/- mice compared to wt mice (P<0.05, wt vs. Atf4-/-). However, their levels were not significantly elevated by the treatment of intermittent PTH in both wt or Atf4-/- animals (P>0.05, veh vs. PTH).
###end p 27
###begin title 28
###xml 81 85 <span type="species:ncbi:10090">mice</span>
Effects of PTH on expression of osteoblast marker genes in wt and ATF4 deficient mice.
###end title 28
###begin p 29
###xml 141 145 141 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4</italic>
###xml 147 150 147 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ocn</italic>
###xml 152 155 152 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bsp</italic>
###xml 157 165 157 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col 1(I)</italic>
###xml 167 170 167 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALP</italic>
###xml 172 175 172 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Opn</italic>
###xml 177 182 177 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pthrp</italic>
###xml 184 189 184 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-Fos</italic>
###xml 191 200 191 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">and c-Jun</italic>
###xml 233 238 233 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gapdh</italic>
###xml 268 269 268 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 292 295 292 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 288 295 288 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 444 450 444 445 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
###xml 473 476 468 471 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 469 476 464 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 483 484 478 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 519 522 514 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 515 522 510 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
A, quantitative real-time PCR, total RNAs were isolated from tibiae and analyzed by quantitative real-time RT-PCR using specific primers for Atf4, Ocn, Bsp, Col 1(I), ALP, Opn, Pthrp, c-Fos, and c-Jun mRNAs, which were normalized to Gapdh mRNA. *P<0.05 (veh vs. PTH), #P<0.05 (wt-veh vs. Atf4-/--veh). B, plasma levels of IGF-1 and FGF-2 from mice using respective ELISA kits according to the manufacturer's instructions. *P<0.05 (veh vs. PTH),daggerP<0.05 (wt-veh vs. Atf4-/--veh), #P<0.05 (PTH/veh-wt vs. PTH/veh-Atf4-/-).
###end p 29
###begin title 30
Intermittent PTH increases in vivo Osx expression in osteoblasts through a pathway requiring ATF4
###end title 30
###begin p 31
###xml 483 486 483 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 479 486 479 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 549 555 549 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g006">Fig. 6</xref>
###xml 701 721 701 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g006">Fig. 6A1, B1, and D1</xref>
###xml 793 801 793 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g006">Fig. 6C1</xref>
###xml 1283 1286 1283 1286 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1279 1286 1279 1286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 1293 1299 1293 1299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g001">Fig. 1</xref>
###xml 1304 1305 1304 1305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g002">2</xref>
###xml 1370 1373 1370 1373 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1366 1373 1366 1373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 1426 1433 1426 1433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g006">Fig. 6E</xref>
###xml 1590 1597 1590 1597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g006">Fig. 6I</xref>
###xml 1792 1795 1792 1795 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1788 1795 1788 1795 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 1805 1812 1805 1812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g006">Fig. 6I</xref>
###xml 1907 1910 1907 1910 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1903 1910 1903 1910 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 2119 2126 2119 2126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g006">Fig. 6F</xref>
###xml 2468 2472 2468 2472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Koh1">[46]</xref>
###xml 2651 2664 2651 2664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g006">Fig. 6F and I</xref>
###xml 2726 2729 2726 2729 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2722 2729 2722 2729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 2963 2966 2963 2966 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2959 2966 2959 2966 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 487 491 <span type="species:ncbi:10090">mice</span>
###xml 1121 1125 <span type="species:ncbi:10090">mice</span>
###xml 2730 2734 <span type="species:ncbi:10090">mice</span>
Our above results demonstrate that ATF4 is essential for the major anabolic actions of PTH on bone and is also required for PTH-dependent induction of osteoblast differentiation. To begin to address the mechanism underlying this response, we measured the expression of Osterix (Osx) and Runx2 proteins, two critical transcription factors that regulate osteoblast differentiation. Initially, we used immunohistochemistry (IHC) to measure Osx in the tibiae and calvariae of wt and Atf4-/- mice with or without 28 d anabolic PTH treatment. As shown in Fig. 6, in wt-vehicle-treated tibiae, Osx-positive osteoblasts were only identified in the trabeculae and cortical endosteum close to the growth plate (Fig. 6A1, B1, and D1) and were almost undetectable in the same regions close to the marrow (Fig. 6C1), indicating that cells in these areas are still in the immature (preosteoblast) state. In contrast, in the wt-PTH group, Osx-positive osteoblasts were identified on all surfaces of trabeculae and endosteum throughout the tibia. PTH increased the total number of Osx-positive cells per tibial section by 3.2-fold in wt mice (Panel 2). ATF4 deficiency reduced the numbers of Osx-positive cells by 50 percent (Panel 3). Strikingly, although PTH slightly increased bone volume in Atf4-/- bone (Fig. 1 and 2), it failed to elevate the numbers of Osx-positive cells in Atf4-/- tibiae. Similar results were obtained in calvariae (Fig. 6E). The IHC staining was highly specific since no signal was detected in the non-immune IgG control group (Panel 5). Consistent with IHC results, as shown in Fig. 6I, Western blot analysis using protein extracts showed that PTH dramatically elevated the level of Osx protein in wt tibiae. In contrast, Osx was not detected by Western blot in extracts from Atf4-/- animals (Fig. 6I). The level of Runx2 protein was slightly up-regulated by PTH in the wt group, but not in Atf4-/- group. Unlike Osx, the basal level of Runx2 was not reduced by ATF4 deficiency. PTH1R protein, the major receptor for PTH and PTHrP signaling in osteoblasts, was expressed in endosteal osteoblasts of tibiae (Fig. 6F) and periosteal osteoblasts of calvariae and hypertrophic chrodrocytes in the growth plate area (unpublished data). The signal for PTH1R protein was weak in trabecular osteoblasts that actively form new bone (unpublished data). In contrast to results from a previous study showing that PTH1R is down-regulated by PTH in cultured osteoblasts [46], PTH1R was slightly increased by intermittent PTH treatment in vivo as measured by IHC and Western blot analysis. Importantly, ATF4 deficiency did not reduce the level of PTH1R (Fig. 6F and I). In addition, primary calvarial osteoblasts from wt and Atf4-/- mice displayed an identical cAMP accumulation curve in response to treatment of increasing concentrations of PTH in vitro. Taken together, these results indicate that the impaired anabolic response of skeleton to PTH observed in Atf4-/- animals cannot be explained by a reduction in the level of PTH1R and/or cAMP production. These results clearly demonstrate that: i) intermittent PTH stimulates the expression of Osx and, to a lesser extent, Runx2, ii) PTH fails to stimulate Osx/Runx2 expression in the absence of ATF4, and iii) ATF4 is also required for basal level Osx expression.
###end p 31
###begin title 32
PTH fails to promote osteoblast maturation/differentiation in the absence of ATF4.
###end title 32
###begin p 33
###xml 631 638 631 633 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> &#8224;</sup>
###xml 662 665 657 660 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 658 665 653 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 672 673 667 668 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 708 711 703 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 704 711 699 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 782 785 777 780 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 778 785 773 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 831 832 826 827 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 786 790 <span type="species:ncbi:10090">mice</span>
###xml 908 913 <span type="species:ncbi:9606">human</span>
A-E, IHC analysis of Osx expression, sections of tibiae (A-D) and calvariae (E) were immunohistochemically stained using a specific antibody against Osx protein. The nuclei of Osx-positive cells (i.e., osteoblasts) were stained brown. The nuclei of preosteoblasts and other cells are stained blue. The total numbers of Osx-positive osteoblasts per tibial (G) or calvarial (H) section were counted under microscope. F, sections of tibiae were stained using an antibody against PTH1R protein. I, Western blot analysis, protein extracts were isolated from tibiae and analyzed for Osx, Runx2, and PTH1R proteins. *P<0.05 (veh vs. PTH), dagger P<0.05 (wt-veh vs. Atf4-/--veh), #P<0.05 (PTH/veh-wt vs. PTH/veh-Atf4-/-). J, cAMP assay, primary calvarial osteoblasts from 3-d-old wt or Atf4-/- mice were isolated, seeded at density of 5x104 on 96-well plate, and treated with vehicle or increasing concentrations of human recombinant PTH(1-34) for 5 min followed by measurement of cAMP.
###end p 33
###begin title 34
Identification of a 132-bp ATF4-response element in proximal Osx promoter
###end title 34
###begin p 35
###xml 28 31 28 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 23 31 23 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Runx2<sup>&#8722;/&#8722;</sup></italic>
###xml 37 41 37 41 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Nakashima1">[35]</xref>
###xml 559 566 559 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g007">Fig. 7A</xref>
###xml 768 774 768 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g007">Fig. 7</xref>
###xml 988 991 988 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Osx</italic>
###xml 1175 1178 1175 1178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Osx</italic>
###xml 1510 1517 1510 1517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g007">Fig. 7C</xref>
###xml 1649 1661 1649 1661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s1">Introduction</xref>
###xml 1782 1789 1782 1789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g007">Fig. 7D</xref>
###xml 1804 1811 1804 1811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g007">Fig. 7E</xref>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
###xml 748 753 <span type="species:ncbi:10090">mouse</span>
###xml 1169 1174 <span type="species:ncbi:10090">mouse</span>
Osx is not detected in Runx2-/- mice [35], indicating that Runx2 functions upstream of this factor and is essential for Osx expression. However, the results described above showed that ATF4 deficiency dramatically reduced the level of Osx protein without decreasing Runx2, suggesting that Runx2 is not sufficient for the maximal expression of Osx and that ATF4 has an important role in Osx expression. To define the mechanism whereby ATF4 regulates Osx, we examined the effect of ATF4 overexpression on Osx expression in MC-4 preosteoblast cells. As shown in Fig. 7A, ATF4 dose-dependently increased levels of Osx protein (top) and mRNA (bottom). We next examined whether ATF4 up-regulates Osx by increasing gene transcription by using a -1003/+68 mouse Osx promoter (Fig. 7 B). Using COS-7 cells, which lack detectable Runx2, ATF4 had comparable activity to Runx2 in terms of its ability to activate promoter activity (approx. 1.8-fold). Together, ATF4 and Runx2 maximally activated the Osx promoter (3.2-fold induction). To further define the region of the Osx promoter necessary for ATF4 responsiveness, several constructs containing various deletion mutants of the mouse Osx promoter were transiently transfected into COS-7 cells with and without an ATF4 expression plasmid. Results showed that luciferase activity of both control and ATF4-transfected groups decreased with progressively larger 5' deletions. However, ATF4 stimulation was abrogated when a 132-bp region between bp -215 to -83 was deleted (Fig. 7C). A putative ATF4-binding sequence (CTTCCTCA) at -201/-194 bp was identified in this region by using a TRANSFAC retrieval program. Introduction of a 3-bp substitution mutation to this core sequence (from CTTCCTCA to CTTgtaCA) completely abolished ATF4 activation (Fig. 7D). As shown in Fig. 7E, a DNA oligo probe from the Osx promoter that contains the TTACATCA core sequence bound to a factor(s) in nuclear extracts from COS-7 cells transfected with an ATF4 expression vector. Importantly, this binding (see arrow) was dramatically reduced by the addition of a specific antibody against ATF4 but not by normal control IgG or antibodies against cFos (an AP1 family member) or ATF2.
###end p 35
###begin title 36
PTH activates Osx gene transcription via an ATF4-responsive element in the proximal Osx promoter.
###end title 36
###begin p 37
###xml 1033 1035 1029 1031 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 1113 1115 1109 1111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 1211 1218 1203 1210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g007">Fig. 7C</xref>
###xml 1251 1253 1243 1245 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 1340 1342 1332 1334 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 1451 1454 1443 1446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Osx</italic>
###xml 1459 1470 1451 1462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">osteocalcin</italic>
###xml 1490 1501 1482 1493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">osteocalcin</italic>
###xml 1529 1532 1521 1524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Osx</italic>
###xml 1583 1585 1575 1577 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 1674 1675 1663 1664 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 165 169 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 312 316 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 506 510 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 957 961 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
A, MC-4 cells were electroporated with indicated amount of ATF4 expression plasmid followed by Western blot. B, COS-7 cells were transfected with p1060mOsx-luc, pRL-SV40, and indicated expression vectors followed by dual lucferase assays. C, COS-7 cells were transfected with various deletion constructs and pRL-SV40 with and without ATF4 expression plasmid. D, COS-7 cells transfected with p215mOsx-luc or the same plasmid containing a 3-bp substitution mutation in the putative ATF4-binding site and pRL-SV40 with and without ATF4 expression plasmid. E, EMSA, labeled wild-type DNA probe was incubated with 2 microg nuclear extracts from COS-7 cells transfected with pCMV/ATF4 plasmid in the presence of normal control IgG (lane 3), ATF4 antibody (lane 4), cFos antibody (lane 5), and ATF2 antibody (lane 6). Experiments were repeated 3-4 times and qualitatively identical results were obtained. F and G, MC-4 cells transfected with p1003mOsx-luc and pRL-SV40 were treated with indicated concentration of PTH for 6 h (F) or with 10-7 M PTH for indicated times (G). H, MC-4 cells were treated with and without 10-7 M PTH in the presence and absence of 10 microM of H89 for 6 h. I, MC-4 cells transfected as in Fig. 7C were treated with and without 10-7 M PTH for 6 h. J, MC-4 cells transfected as in Fig. D were treated with and without 10-7 M PTH for 6 h. K, a schematic illustration of putative ATF4 binding sites in the 5' flanking regions of the Osx and osteocalcin gene promoters and osteocalcin gene. L, ChIP assay of the Osx promoter in MC-4 cells treated with and without 10-7 M PTH for 6 h. *P<0.05 (beta-gal vs. ATF4, Runx2, and ATF4 plus Runx2, or veh vs. PTH), #P<0.05 (ATF4 plus Runx2 vs. beta-gal, ATF4, or Runx2).
###end p 37
###begin title 38
PTH stimulation of Osx gene transcription requires an ATF4 response element
###end title 38
###begin p 39
###xml 45 48 45 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Osx</italic>
###xml 105 108 105 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Osx</italic>
###xml 174 181 174 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g007">Fig. 7F</xref>
###xml 303 306 303 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;10</sup>
###xml 364 367 364 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Osx</italic>
###xml 463 470 463 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g007">Fig. 7G</xref>
###xml 551 558 551 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g007">Fig. 7H</xref>
###xml 662 669 662 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g007">Fig. 7I</xref>
###xml 799 806 799 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g007">Fig. 7J</xref>
###xml 89 94 <span type="species:ncbi:10090">mouse</span>
To study the mechanism whereby PTH regulates Osx, we next evaluated the effect of PTH on mouse -1003/+68 Osx promoter activity in MC-4 preosteoblast cells. As illustrated in Fig. 7F, PTH stimulated promoter activity in a dose-dependent manner with a detectable response seen at a PTH concentration of 10-10 M (significance at P<0.01). Measurable activation of the Osx promoter was observed 0.5 h after PTH addition with maximal induction occurring between 4-6 h (Fig. 7G). PTH-stimulated Osx protein expression was entirely blocked by PKA inhibition (Fig. 7H). The 132-bp ATF4-responsive element identified above was also required for PTH induction of promoter (Fig. 7I). Furthermore, the same 3-bp substitution mutation that abrogates ATF4 activation dramatically reduced PTH-dependent activation (Fig. 7J), indicating that this element is critical for the actions of PTH on this promoter.
###end p 39
###begin title 40
ATF4 is recruited to the endogenous Osx promoter in a PTH-dependent manner
###end title 40
###begin p 41
###xml 60 63 60 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Osx</italic>
###xml 200 213 200 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g007">Fig. 7K and L</xref>
###xml 286 289 286 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Osx</italic>
###xml 429 432 429 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 425 432 425 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 596 600 596 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mOG2</italic>
###xml 645 649 645 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Jiang1">[31]</xref>
###xml 651 655 651 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Yu2">[34]</xref>
###xml 750 754 750 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mOG2</italic>
###xml 919 923 919 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mOG2</italic>
###xml 433 437 <span type="species:ncbi:10090">mice</span>
To determine whether ATF4 is associated with the endogenous Osx promoter in vivo, we performed chromatin immunoprecipitation (ChIP) assays using MC-4 cells with and without PTH treatment. As shown in Fig. 7K and L, ATF4 specifically interacted with a chromatin fragment of the proximal Osx promoter that contains the ATF4-binding site identified above. This interaction was not detected in primary calvarial osteoblasts from Atf4-/- mice (data not shown). Furthermore, this interaction was dramatically stimulated by PTH treatment. Supporting our previous demonstration that the OSE1 site in the mOG2 promoter mediates PTH induction of the gene [31], [34], ATF4 also bound to an ATF4-binding site (OSE1)-containing chromatin fragment of the proximal mOG2 promoter in a PTH-dependent manner (primers P3/P4). In contrast, ATF4 antibody failed to immunoprecipitate a 3' chromatin fragment in the transcribed region of the mOG2 gene that contains no ATF4-binding sites (primers P5/P6).
###end p 41
###begin title 42
Discussion
###end title 42
###begin p 43
###xml 420 424 420 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4</italic>
###xml 482 486 482 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4</italic>
###xml 486 489 486 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 435 439 <span type="species:ncbi:10090">mice</span>
###xml 490 494 <span type="species:ncbi:10090">mice</span>
Our goals in this study were: 1) to determine whether the bone-related transcription factor ATF4 plays a role in the anabolic effects of PTH in bone, and 2) if so, to define the relevant mechanisms. Our results clearly show that PTH-stimulated increases in osteoblast proliferation, volume of long bones, vertebrae, and calvariae as well as decreases in apoptosis are all dramatically reduced or completely abolished in Atf4-deficient mice. Equally importantly, PTH-induced bone in Atf4-/- mice cannot mature due to a severe defect in osteoblast differentiation as manifested by a defect in Osx expression. Therefore, this study establishes a critical role for ATF4 in the anabolic actions of PTH in bone.
###end p 43
###begin p 44
###xml 48 52 48 52 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Calvi1">[14]</xref>
###xml 54 58 54 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Jilka2">[47]</xref>
###xml 339 342 339 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Miao1">[2]</xref>
###xml 344 347 344 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Jilka1">[6]</xref>
###xml 349 353 349 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Miao2">[45]</xref>
###xml 355 359 355 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Jilka2">[47]</xref>
###xml 459 463 459 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Datta1">[15]</xref>
###xml 465 469 465 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Bellido1">[16]</xref>
###xml 471 475 471 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Chen2">[48]</xref>
###xml 793 797 793 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Zhang1">[33]</xref>
###xml 858 862 858 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Datta1">[15]</xref>
###xml 864 868 864 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Yu2">[34]</xref>
###xml 1082 1085 1082 1085 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1074 1085 1074 1085 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53/Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 1178 1182 1178 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Tanaka2">[49]</xref>
###xml 1184 1188 1184 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Hettmann1">[50]</xref>
###xml 1086 1090 <span type="species:ncbi:10090">mice</span>
In agreement with results from previous studies [14], [47], we find that intermittent PTH dramatically increases trabecular and cortical bone volume. This PTH response is achieved at least in part by stimulating the proliferation of osteoblasts and preosteoblasts and/or by inhibiting apoptotic death of osteoblasts and osteocytes in vivo [2], [6], [45], [47]. Effects of PTH on osteoblast proliferation and survival can be reproduced in cultured osteoblasts [15], [16], [48]. Importantly, this study demonstrates that ATF4 plays a pivotal role in PTH stimulation of cell proliferation in osteoblasts and preosteoblasts and attenuation of apoptosis in osteoblasts and osteocytes in vivo. PTH can increase osteoblast proliferation at least in part through ATF4-mediated expression of cyclin D1 [33] because both factors are up-regulated by PTH in osteoblasts [15], [34]. The mechanism whereby ATF4 blocks apoptosis in osteoblasts remains unknown. ATF4 deficiency also increases apoptosis in lens fiber cells in a p53-dependent manner. The embryonic lens in double homozygous p53/Atf4-/- mice does not undergo apoptosis, which suggests possible involvement of p53 in this process [49], [50].
###end p 44
###begin p 45
###xml 159 162 159 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-IidaKlein1">[4]</xref>
###xml 164 168 164 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Wang1">[51]</xref>
###xml 169 173 169 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Kaback1">[53]</xref>
###xml 360 363 360 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ocn</italic>
###xml 365 368 365 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bsp</italic>
###xml 370 373 370 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alp</italic>
###xml 375 378 375 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Opn</italic>
###xml 384 391 384 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col1(I)</italic>
###xml 721 725 721 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Carpio1">[12]</xref>
###xml 727 731 727 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Yu1">[30]</xref>
###xml 733 737 733 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Jiang1">[31]</xref>
###xml 739 743 739 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Boguslawski1">[54]</xref>
###xml 744 748 744 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-vanderHorst1">[57]</xref>
Accumulating evidence supports the concept that, in addition to increasing osteoblast cell number, intermittent PTH also stimulates osteoblast differentiation [4], [51]-[53]. In agreement with these results, the present study clearly demonstrates that: i) PTH dramatically increases the in vivo expression of osteoblast differentiation marker genes, including Ocn, Bsp, Alp, Opn, and Col1(I); and ii) PTH strikingly elevates the numbers of Osx-positive osteoblasts (i.e., mature or differentiating osteoblasts) and level of Osx protein as demonstrated by both IHC and Western blot analysis. Because PTH is able to stimulate the expression of many osteoblast differentiation marker genes in cultured osteoblast-like cells [12], [30], [31], [54]-[57], it is likely that intermittent PTH also activates these genes in vivo via a similar molecular mechanism. Although part of the increased osteoblast activity in PTH-treated animals is likely explained by a PTH-dependent increase in osteoblast proliferation and/or reduction of apoptosis, our studies suggest that PTH also increases osteoblast differentiation by rapidly up-regulating Osx.
###end p 45
###begin p 46
###xml 180 183 180 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 176 183 176 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 272 279 272 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g001">Figs. 1</xref>
###xml 280 280 280 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g002"/>
###xml 280 281 280 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g003">3</xref>
###xml 426 429 426 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 422 429 422 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 570 573 570 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 566 573 566 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
Importantly, experiments from the current study show that effects of PTH on osteoblast differentiation are mediated by ATF4. Although PTH increased osteoblast proliferation in Atf4-/- animals as evidenced by significant increases in bone volume and nuclear BrdU labeling (Figs. 1-3), expression of osteoblast marker genes and numbers of Osx-positive osteoblasts were either dramatically reduced or completely abolished in Atf4-/- animals. Furthermore, since the basal levels of osteoblast differentiation markers are either slightly reduced or not changed at all in Atf4-/- animals, the impaired differentiation response to PTH cannot be explained by a nonspecific blockage in osteoblast differentiation associated with ATF4 deficiency. Instead, ATF4 appears to have a unique role in the PTH-dependent component of osteoblast differentiation.
###end p 46
###begin p 47
###xml 279 282 279 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Osx</italic>
###xml 442 445 442 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Osx</italic>
###xml 456 468 456 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s1">Introduction</xref>
###xml 699 702 699 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Osx</italic>
###xml 775 778 775 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Osx</italic>
###xml 436 441 <span type="species:ncbi:10090">mouse</span>
Further support for the concept that PTH actions are mediated by ATF4 comes from mechanistic studies. Specifically, we showed that PTH is a potent inducer of Osx expression in vivo and this response is completely abolished by ATF4 deficiency. Furthermore, PTH directly activated Osx gene transcription in cultured osteoblast-like cells, a response that required an ATF4 response element located between -201 and -194 bp in the proximal mouse Osx promoter. Introduction of a 3-bp substitution mutation into this ATF4-binding site essentially eliminated the PTH response. ChIP assays demonstrated that ATF4 binds to an endogenous chromatin fragment near the putative ATF4-binding site in the proximal Osx promoter in MC-4 cells. Of particular significance, ATF4 binding to the Osx promoter is dramatically enhanced by PTH. Collectively, these studies establish a unique role for ATF4 in PTH-mediated induction of Osx and osteoblast differentiation.
###end p 47
###begin p 48
###xml 96 100 96 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Nakashima1">[35]</xref>
###xml 102 106 102 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Karsenty1">[58]</xref>
###xml 721 724 721 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ocn</italic>
###xml 730 734 730 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Xiao1">[59]</xref>
###xml 483 488 <span type="species:ncbi:10090">mouse</span>
Runx2 is absolutely required for Osx expression, osteoblast differentiation, and bone formation [35], [58]. Nevertheless, ATF4 deficiency dramatically reduced the level of Osx protein without altering Runx2, suggesting that Runx2 is not sufficient for maximal Osx expression. ATF4 stimulated Osx gene transcription in COS-7 cells that lack Runx2 protein to an extent similar to that seen with Runx2. In addition, an ATF4 response element was identified in the proximal region of the mouse Osx promoter. These results demonstrate that both ATF4 and Runx2 are essential for the maximal expression of Osx and are reminiscent of our previous study showing cooperative interactions between these two factors in regulating the Ocn gene [59].
###end p 48
###begin p 49
###xml 175 179 175 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4</italic>
###xml 179 182 179 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 189 196 189 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g001">Figs. 1</xref>
###xml 197 197 197 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g002"/>
###xml 197 198 197 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g003">3</xref>
###xml 279 282 279 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Demiralp1">[3]</xref>
###xml 329 333 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Bellido1">[16]</xref>
###xml 433 437 433 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Liu1">[60]</xref>
###xml 449 453 449 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Bellido1">[16]</xref>
###xml 455 459 455 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Krishnan1">[23]</xref>
###xml 739 743 739 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Xiao1">[59]</xref>
###xml 745 749 745 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Dobreva1">[61]</xref>
###xml 750 754 750 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Hess1">[65]</xref>
###xml 819 823 819 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Wan1">[66]</xref>
###xml 183 187 <span type="species:ncbi:10090">mice</span>
It should be noted that ATF4 deficiency did not completely block the anabolic actions of PTH since this hormone increased bone volume in both growing and adult OVX bones from Atf4-/- mice (Figs. 1-3). This suggests that other factors must be involved for the PTH response. c-Fos [3], cAMP response element binding protein (CREB) [16], a major downstream target for PTH/cAMP and calcium signals, cAMP-response element modulator (CREM)[60], and Runx2 [16], [23], a master regulator of osteoblast differentiation and bone formation, have all been shown to mediate components of the PTH anabolic response. Interestingly, these factors are either structurally related to ATF4 (c-Fos and CREM) or can interact with this factor (Runx2 and c-Fos) [59], [61]-[65]. Most recently, low-density lipoprotein-related protein 6 (LRP6)[66], a major component of the Wnt signaling pathway, has been implicated in the anabolic actions of PTH in bone. It would be interesting to determine whether ATF4 mediates the PTH anabolic response via interactions with these factors or signaling pathways.
###end p 49
###begin p 50
###xml 80 84 80 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4</italic>
###xml 161 165 161 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Yu2">[34]</xref>
###xml 186 192 186 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g005">Fig. 5</xref>
###xml 251 255 251 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Yu2">[34]</xref>
###xml 393 398 390 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rankl</italic>
###xml 430 434 427 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Elefteriou1">[67]</xref>
###xml 499 503 496 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Yang1">[26]</xref>
###xml 710 714 707 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Yang1">[26]</xref>
###xml 757 761 754 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Chen2">[48]</xref>
###xml 974 978 971 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Xiao1">[59]</xref>
###xml 980 984 977 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Dobreva1">[61]</xref>
###xml 986 990 983 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Tominaga1">[63]</xref>
###xml 1079 1083 1076 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Krishnan1">[23]</xref>
###xml 1085 1089 1082 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Yu2">[34]</xref>
PTH signaling may regulate ATF4 via several mechanisms. First, PTH up-regulates Atf4 gene expression in cultured osteoblasts as demonstrated by our recent study [34] as well as in vivo (Fig. 5). Second, PTH post-translationally activates ATF4 via PKA [34], a major route for PTH signaling in osteoblasts. PKA phosphorylation of ATF4 at its Ser254 residue mediates beta-adrenergic induction of Rankl mRNA expression in osteoblasts [67]. ATF4 can also be directly phosphorylated and activated by RSK2 [26], a growth factor-regulated serine-threonine protein kinase activated by the Ras-Mitogen-Activated Protein Kinase (MAPK) pathway. This phosphorylation is critical for ATF4 activity as well as bone formation [26]. Because PTH signaling activates Erk/MAPK [48], an immediate upstream activator of RSK2, ATF4 can be activated via the PTH-MAPK-RSK2 signaling pathway. Lastly, PTH promotes ATF4-Runx2 interactions which are critical for osteoblast function and bone formation [59], [61], [63]. This notion is supported by the fact that PTH up-regulates both factors in osteoblasts [23], [34].
###end p 50
###begin p 51
###xml 154 160 154 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g008">Fig. 8</xref>
###xml 880 884 880 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Zhang2">[68]</xref>
Based on findings from this and other studies, we proposed a working model for ATF4 to mediate PTH stimulation of osteoblast function and bone formation (Fig. 8). Binding of PTH to its receptor, PTH1R, activates PKA and probably other intracellular signaling pathways, leading to up-regulation/activation of ATF4. ATF4 subsequently increases proliferation of osteoblasts and/or preosteoblasts via modulation of cyclin D1 protein, and attenuates apoptotic death in osteoblasts and osteocytes, resulting in a significant increase in the numbers of osteoblasts and/or osteocytes. At the same time, ATF4 together with Runx2 maximally activates Osx expression and increases osteoblast differentiation. The resulting increases in osteoblast number and differentiation lead to bone formation. Osx also negatively regulates osteoblast proliferation, thus preventing excess bone formation [68].
###end p 51
###begin title 52
Proposed model for ATF4 mediation of PTH stimulation of bone formation.
###end title 52
###begin p 53
Binding of PTH to PTH1R activates PKA and leads to up-regulation of ATF4. ATF4 subsequently increases proliferation and survival of osteoblasts. At the same time, ATF4 together with Runx2 maximally activates Osx expression and increases osteoblast differentiation. These increases in osteoblast number and differentiation lead to massive bone formation. Osx also negatively regulates osteoblast proliferation, thus preventing excess bone formation.
###end p 53
###begin p 54
###xml 110 114 110 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Elefteriou1">[67]</xref>
###xml 116 120 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Elefteriou2">[69]</xref>
Since ATF4 is known to regulate the expression of RANKL in osteoblasts and thereby osteoclast differentiation [67], [69], it will be interesting to determine if ATF4 is also required for the catabolic actions of PTH in bone.
###end p 54
###begin p 55
In summary, this study establishes a critical role for ATF4 in the anabolic actions of PTH in bone. ATF4 is necessary for PTH to increase both osteoblast numbers and differentiation. Therefore, ATF4 may provide a potential new therapeutic target for improving bone mass and for treating metabolic bone diseases such as osteoporosis.
###end p 55
###begin title 56
Materials and Methods
###end title 56
###begin title 57
Reagents
###end title 57
###begin p 58
###xml 31 37 <span type="species:ncbi:9913">bovine</span>
###xml 111 116 <span type="species:ncbi:10090">mouse</span>
###xml 330 341 <span type="species:ncbi:3704">horseradish</span>
###xml 364 369 <span type="species:ncbi:10090">mouse</span>
###xml 373 377 <span type="species:ncbi:9925">goat</span>
Tissue culture media and fetal bovine serum were obtained from HyClone (Logan, UT). H89, DMSO, PTH1R antibody, mouse monoclonal antibody against beta-actin were purchased from Sigma (St Louis, MO). Other reagents were obtained from the following sources: antibodies against ATF4 (for Western blot), Runx2, normal control IgGs and horseradish peroxidase-conjugated mouse or goat IgG from Santa Cruz (Santa Cruz, CA), and Osterix antibody from Abcam Inc. (Cambridge, MA). ATF4 antibody used for EMSA was raised against epitope QETNKEPPQTVNPIGHLPESLIK (St Louis, MO). All other chemicals were of analytical grade.
###end p 58
###begin title 59
###xml 15 19 <span type="species:ncbi:10090">mice</span>
Atf4-deficient mice
###end title 59
###begin p 60
###xml 18 22 18 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4</italic>
###xml 67 71 67 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Yu2">[34]</xref>
###xml 93 97 93 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4</italic>
###xml 114 118 114 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4</italic>
###xml 118 121 118 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 138 142 138 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4</italic>
###xml 142 145 142 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 170 174 170 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4</italic>
###xml 174 177 174 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
###xml 179 183 <span type="species:ncbi:10090">mice</span>
Breeding pairs of Atf4 heterozygous mice were described previously [34] and used to generate Atf4 wild-type (wt) (Atf4+/+), heterozygous (Atf4+/-) and homozygous mutant (Atf4-/-) mice for this study. All research protocols were approved by the Institutional Animal Care and Use Committee of the VA Pittsburgh Healthcare System, where this study was conducted.
###end p 60
###begin title 61
In vivo PTH administration
###end title 61
###begin p 62
###xml 17 22 <span type="species:ncbi:10090">mouse</span>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 197 202 <span type="species:ncbi:10090">mouse</span>
###xml 233 237 <span type="species:ncbi:10090">mice</span>
###xml 1034 1038 <span type="species:ncbi:10090">mice</span>
###xml 1138 1142 <span type="species:ncbi:10090">Mice</span>
For the "growing mouse model", five-day-old mice were given daily subcutaneous injections of vehicle (saline) or hPTH(1-34) (60 ng/g body weight, Bachem, Torrance, CA) for 28 d. For the "adult OVX mouse model", four-month-old female mice were anesthetized and ovariectomized as follows: A 1-cm midline incision was made through the skin. The "white line" will be visualized on the peritoneum and a second incision was made along the white line through the peritoneum. Using long, straight forceps, the left ovary was isolated and the connective tissue between the ovary and kidney was dissected away. Straight forceps with flat ends was used to pinch the uterine horn while another set of straight forceps was used to tear the ovary away from the uterine horn. The same was done on the right ovary. 6-0 PDS (Polydioxanone Sutures, 6/0) was used to tie around the uterine horn to provide hemostasis if necessary. 6-0 PDS was used to close the innermost layer. Sterile surgical staples were used to close the incision. Two months later mice were given daily subcutaneous injections of vehicle or hPTH(1-34) (100 ng/g body weight) for 28 d. Mice were euthanized 24 h after last PTH injection. The effects of these PTH dosing regimens on bone were determined by both biochemical and histomorphometric criteria.
###end p 62
###begin title 63
Gross evaluation and serum biochemistry
###end title 63
###begin p 64
Body weight was recorded every another day. The length of the femurs was measured using an electronic digital caliper. Faxitron X-ray analysis of femurs was conducted at 27 kv and 7.5 seconds (Faxitron X-Ray Corp., Wheeling, IL). Femurs were ashed at 800degreesC for 4 h and weighed. Serum calcium and Pi concentrations were determined using kits from Pointe Scientific, Inc (Canton, MI) following the manufacture's instructions (Sigma Diagnostics).
###end p 64
###begin title 65
###xml 64 65 63 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
Bone morphometric analyses by micro-computerized tomography (muCT)
###end title 65
###begin p 66
###xml 336 340 335 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Parfitt1">[70]</xref>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
Upon termination of PTH or vehicle treatment, mice were sacrificed and femurs were isolated. Fixed non-demineralized femurs were used for muCT analysis at the Center for Bone Biology using a VIVACT40 (SCANCO Medical AG) following the standards of techniques and terminology recommended by American Society for Bone and Mineral Research [70]. For trabecular bone parameters, transverse CT slices were obtained in the region of interest in the axial direction from the trabecular bone 0.1 mm below the growth plate (bottom of the primary spongiosa) to the mid-femur. Contours were defined and drawn close to the cortical bone. The trabecular bone was then removed and analyzed separately. 3D analysis was then performed on trabecular bones slices. A 3-mm section was used to obtain mid-femoral cortical bone thickness. The analysis of the specimens involves the following bone measurements: bone volume fraction (BV/TV, %), trabecular number (Tb. N), trabecular thickness (Tb. Th), trabecular spacing (Tb. Sp), and cortical thickness (Cort.Th).
###end p 66
###begin title 67
Histological evaluation
###end title 67
###begin p 68
###xml 710 714 700 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Zhao1">[71]</xref>
Tibiae, lumbar vertebrae (L5), and calvariae were fixed in PBS buffered 10% formalin at 4degreesC for 24 h, decalcified in 10% EDTA (pH 7.4) for 10-14 d, and embedded in paraffin. Longitudinal sections of tibiae and vertebrae were cut at 4 microm and stained with hematoxylin and eosin (H&E). Trabecular area of tibial sections was measured in the proximal metaphysis beginning immediately below the chondro-osseous junction to the mid-tibia. Calvariae were bisected perpendicular to the sagittal suture through the central portion of the parietal bones, parallel to lamboidal and coronal sutures, and embedded in paraffin to obtain sections of a standard area according to the method described by Zhao et al. [71]. Trabecular area versus total bone area was measured using an Image Pro Plus 6.2 software (Media Cybernetics, Inc, Bethesda, MD). The calvarial width was the average value from 20 random measurements of each calvaria (at least 6 samples per group) using a SPOT Advanced imaging software (provided with the purchase of the Olympus BX41 microscope).
###end p 68
###begin title 69
Measurement of mineral apposition rate (MAR)
###end title 69
###begin p 70
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were injected with calcein subcutaneously (20 mg/kg) at 6 and 2 d before sacrifice. Undecalcified tibia were fixed in 70% ethanol, embedded in methylmethacrylate and sectioned at 10 microm. Calcein labeling was visualized using a Nikon E800 fluorescence microscope. The metaphyseal trabecular bone projected into the marrow space was evaluated and the distance between the all double-labeled areas was measured at a magnification of 200x. MAR was calculated as mean distance between the double labels divided by the number of the days between the calcein injections. Histomorphometric analysis was performed using BioQuant image analysis software (R&M Bio Metrics, Nashville, TN, USA).
###end p 70
###begin title 71
In vivo proliferation assay
###end title 71
###begin p 72
###xml 584 588 576 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Zhang1">[33]</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were injected intraperitoneally with 100 microg bromodeoxyuridine (BrdU)/12 microg fluorodeoxyuridine (FdU) per gram of body weight 12 h before sacrifice. After sacrifice, sections of tibiae and calvariae were obtained. To identify actively proliferating cells, nuclei that have incorporated BrdU were detected using a Zymed BrdU immunostaining kit according to the manufacturer's instruction (Invitrogen, Carlsbad, CA). BrdU-positive cells (brown) on the calvarial periosteal surface or in the osteoid of tibiae were counted and normalized to the total numbers in the same area [33]. BrdU-positive hematopoietic cells in marrow were not counted.
###end p 72
###begin title 73
In situ apoptosis detection
###end title 73
###begin p 74
###xml 185 192 181 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Situ</italic>
This assay is based on the classical TUNEL assay to examine apoptosis by detecting DNA fragmentation. 4-microm sections of tibiae were prepared and stained using the ApopTag Peroxidase In Situ Apoptosis Detection Kit according to the manufacturer's instruction (Millipore, Billerica, MA). Apoptotic osteoblasts and osteocytes in tibiae were counted and normalized to the total cells from the same area.
###end p 74
###begin title 75
Immunohistochemistry (IHC)
###end title 75
###begin p 76
###xml 224 225 224 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 629 630 617 618 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 631 632 619 620 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 932 938 <span type="species:ncbi:9793">donkey</span>
###xml 944 950 <span type="species:ncbi:9986">rabbit</span>
Tibiae and calvariae were fixed, decalcified, and embedded in paraffin. Sections of tibiae and calvariae were stained with antibodies against Osx (Abcam Inc, Cambridge, MA) and PTH1R (Sigma, St. Louis, MO) using the EnVision+System-HRP (DAB) kit (Dako North America, Inc, Carpinteria, CA) according to the manufacturer's instructions. Briefly, slides were baked at 55degreesC for 45 min, deparaffinized in three washes of xylene, and rehydrated in a decreasing ethanol gradient. Antigen retrieval was performed using 0.1% trypsin for 10 min at 37degreesC in a humidified chamber. Endogenous peroxidases were deactivated with 3% H2O2 in 1x PBS for 10 min, and sections were blocked in blocking solution for 30 min at room temperature. Sections were incubated with primary antibody (1:200 dilution for both osterix and PTH1R) in blocking solution for 2 hours at 4degreesC. Sections were washed in PBS three times and incubated with a donkey-anti-rabbit IgG-HRP secondary antibody solution for 30 min at room temperature. After washing with PBS three times, HRP activity was detected using a DAB substrate solution for 5 min at room temperature. Sections were counter-stained with a Mayer's hematoxylin solution.
###end p 76
###begin title 77
Measurement of plasma levels of IGF-1 and FGF-2 by ELISA
###end title 77
###begin p 78
###xml 65 69 <span type="species:ncbi:10090">mice</span>
###xml 156 161 <span type="species:ncbi:9606">human</span>
###xml 194 197 <span type="species:ncbi:9685">cat</span>
###xml 211 216 <span type="species:ncbi:10090">mouse</span>
###xml 245 248 <span type="species:ncbi:9685">cat</span>
Blood plasma samples were prepared from whole-blood samples from mice of each group and plasma levels of IGF-1 and FGF-2 were measured by using ELISA kits (human FGF basic Quantikine ELISA Kit, cat#: DFB50, and mouse IGF-I Quantikine ELISA Kit, cat#: MG100, both from R&D Systems Inc, Minnepolis, MN 55413) according to the manufacturer's instructions.
###end p 78
###begin title 79
cAMP assay
###end title 79
###begin p 80
###xml 56 59 56 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 52 59 52 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atf4<sup>&#8722;/&#8722;</sup></italic>
###xml 103 107 103 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Ducy3">[72]</xref>
###xml 146 147 146 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
###xml 227 232 <span type="species:ncbi:9606">human</span>
###xml 397 400 <span type="species:ncbi:9685">cat</span>
Primary osteoblasts from calvariae of 3-d-old wt or Atf4-/- mice were isolated as described previously [72]. Cells were seeded at a desity of 5x104/well on 96-well plate and treated with vehicle or increasing concentrations of human recombinant PTH(1-34) for 5 min. Cells were then lysed with lysis reagent 1B and cell lysates used for cAMP assay using a cAMP Biotrak Enzymeimmunoassay (EIA) kit (cat #: RPN225, GE Healthcare Biosciences Corp, Piscataway, NJ) according to the manufacturer's instructions and the protein concentrations were measured using a BCA protein assay kit (Pierce). cAMP was normalized to total protein.
###end p 80
###begin title 81
Quantitative real-time RT/PCR and Western blot analysis
###end title 81
###begin p 82
###xml 135 139 135 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Yu2">[34]</xref>
###xml 218 225 218 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007583-t001">Table 1</xref>
###xml 287 291 287 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Zhang1">[33]</xref>
###xml 162 167 <span type="species:ncbi:10090">mouse</span>
RNA isolation, reverse transcription (RT), regular PCR, and quantitative real-time PCR analysis were performed as previously described [34]. The DNA sequences of mouse primers used for real-time PCR were summarized in Table 1. Western blot analysis was performed as previously described [33]. RNAs or protein extracts from at least six specimens in each group were used.
###end p 82
###begin title 83
real-time PCR primers.
###end title 83
###begin title 84
DNA constructs and site-directed mutagenesis, transfection
###end title 84
###begin p 85
###xml 67 71 64 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Yu3">[62]</xref>
###xml 109 112 106 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Osx</italic>
###xml 617 619 614 616 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 709 781 706 778 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGT ACC CCT CCC TCT CTC GCC TTg taC ATT GGA TCC GGA GTC TTC TCC GC-3&#8242;</named-content>
###xml 793 866 790 863 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCG GAG AAG ACT CCG GAT CCA ATG tac AAG GCG AGA GAG GGA GGC GGT ACC-3&#8242;</named-content>
###xml 103 108 <span type="species:ncbi:10090">mouse</span>
###xml 305 310 <span type="species:ncbi:10090">mouse</span>
pCMV/beta-gal, pCMV/ATF4, and pCMV/Runx2 were previously described [62]. mOsx-luc containing different mouse Osx promoter elements (-1003/+68, -567/+68, -215/+68, and -83/+68) driving a firefly luciferase reporter gene were constructed in the project laboratory by PCR subcloning promoter fragments using mouse tail DNA as a template into pGL3-luc vector (Promega, Madison, WI). Mutant p215mOsx-luc which contains a 3-bp substitution mutation in a putative ATF4-binding at positions -198, -197 and -196 (from CTTCCTCA to CTTgtaCA) was generated from the wild-type p215mOsx-luc by PCR amplification using a QuickChangeTM XL Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA) using the following primers: 5'-GGT ACC CCT CCC TCT CTC GCC TTg taC ATT GGA TCC GGA GTC TTC TCC GC-3' (forward); 5'-GCG GAG AAG ACT CCG GAT CCA ATG tac AAG GCG AGA GAG GGA GGC GGT ACC-3' (reverse). Sequence accuracy was confirmed by automatic DNA sequencing. For all transfection experiments, the amount of plasmid DNAs (reporter plasmid, 0.25 microg; normalization plasmid pRL-SV4, 10 ng; and expression plasmid, 1.0 microg) was balanced as necessary with beta-galactosidase expression plasmid such that the total DNA was constant in each group. Experiments were performed in triplicates and repeated 3-4 times.
###end p 85
###begin title 86
Nuclear extracts preparation and electrophoretic mobility shift assay (EMSA)
###end title 86
###begin p 87
###xml 108 112 108 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Xiao2">[73]</xref>
###xml 187 250 187 250 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GAT CCC TGC CTC CCT CTC TCG CCT TCC TCA TTG GAT CCG GAG TCT TCG</named-content>
###xml 324 327 <span type="species:ncbi:9685">cat</span>
###xml 781 784 <span type="species:ncbi:9685">cat</span>
###xml 959 962 <span type="species:ncbi:9685">cat</span>
Nuclear extracts were prepared from COS-7 cells transfected with pCMV/ATF4 plasmids as previously described [73]. The DNA sequences of the oligonucleotides used for EMSA were as follows: GAT CCC TGC CTC CCT CTC TCG CCT TCC TCA TTG GAT CCG GAG TCT TCG. DNA oligonucleotide was labeled using a Biotin 3' end DNA Labeling Kit (cat #: 89818, Pierce Biotechnology Inc., Rockford, IL). Two microg of nuclear extracts and 20 fmol biotin-labeled DNA probe were incubated in 1x binding buffer for 30 min at room temperature. For supershift assay, 1 microg of IgG or indicated antibodies were first incubated with nuclear extracts prior to addition of DNA probe. Protein-DNA complexes were separated on 4% polyacrylamide gels in 1x TBE buffer, and transferred onto Biodyne B Nylon Membrane (cat #: 77016, Pierce). The membrane was blocked in 1x blocking buffer, washed five times with 1x wash buffer, and visualized by a Chemiluminescent Nucleic Acid detection Module (cat #: 89880, Pierce, Rockford, IL).
###end p 87
###begin title 88
Chromatin immunoprecipitation (ChIP)
###end title 88
###begin p 89
###xml 86 90 86 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Yu3">[62]</xref>
###xml 110 117 110 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007583-t002">Table 2</xref>
###xml 200 209 200 209 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CTTCCTCAT</named-content>
###xml 322 325 322 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Osx</italic>
###xml 388 399 388 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">osteocalcin</italic>
###xml 533 537 533 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007583-Yu3">[62]</xref>
ChIP assays were performed using ATF4 antibody or control IgG as described previously [62]. PCR primer pairs (Table 2) were generated to detect DNA segments located near a putative ATF4-binding site (CTTCCTCAT) at -201/-193 (primers P1 and P2) determined by the TRANSFAC retrieval program in the 5' flanking region of the Osx promoter, a previously identified ATF4-binding site (OSE1) in osteocalcin gene 2 (mOG2) promoter (primers 3 and 4), and a mOG2 gene region (+177/+311) that contains no ATF4-binding sites (primers P5 and P6) [62]. PCR products were run on 3% agarose gel and stained with ethidium bromide. Purified input chromatin was used to perform parallel PCRs with the respective primer pairs.
###end p 89
###begin title 90
PCR primers used in ChIP assay.
###end title 90
###begin title 91
Statistical analysis
###end title 91
###begin p 92
###xml 128 129 128 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 214 221 214 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g001">Figs. 1</xref>
###xml 223 224 223 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g002">2</xref>
###xml 226 227 226 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g004">4</xref>
###xml 233 234 233 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g005">5</xref>
###xml 239 243 239 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007583.s001">S1-2</xref>
###xml 271 278 271 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007583-g003">Figs. 3</xref>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007583.s003">S3</xref>
###xml 262 266 <span type="species:ncbi:10090">mice</span>
###xml 307 311 <span type="species:ncbi:10090">mice</span>
Data was analyzed with a GraphPad Prism software (4.0). A one-way ANOVA analysis was used followed by the Tukey test. Students' t test was used to test for differences between two groups of data as needed. Data of Figs. 1, 2, 4, and 5 and S1-2 were from growing mice and Figs. 3 and S3 from 7-month-old OVX mice. For H&E, IHC, BrdU, and TUNEL studies, two to three sections per specimen and at least six specimens in each group were used. Results were expressed as means +/- standard deviation (SD). Differences with a P<0.05 was considered as statistically significant.
###end p 92
###begin title 93
Supporting Information
###end title 93
###begin p 94
###xml 146 150 <span type="species:ncbi:10090">mice</span>
Effects of PTH on animal growth, length and ash weight of femurs, and serum Pi and calcium concentrations and alkaline activity in wt and Atf4-/- mice. A, growth curve, B, length of femur, C, dry ash weight of femur, D, serum Pi, E, serum calcium. *P<0.05 (veh vs. PTH), dagger P<0.05 (wt-veh vs. Atf4-/--veh).
###end p 94
###begin p 95
(1.78 MB TIF)
###end p 95
###begin p 96
Click here for additional data file.
###end p 96
###begin p 97
###xml 96 100 <span type="species:ncbi:10090">mice</span>
Faxitron X-ray analysis of femurs from vehicle and PTH-treated growing wt, Atf4+/-, and Atf4-/- mice. Faxitron X-ray analysis was conducted at 27 kv and 7.5 seconds. Representative microradiographic images of femurs are shown.
###end p 97
###begin p 98
(1.45 MB TIF)
###end p 98
###begin p 99
Click here for additional data file.
###end p 99
###begin p 100
###xml 60 64 <span type="species:ncbi:10090">mice</span>
###xml 88 92 <span type="species:ncbi:10090">mice</span>
Effects of OVX surgery on bone parameters in wt and Atf4-/- mice. Four-month-old female mice were first ovariectomized. After two months, femurs were isolated for muCT analysis. *P<0.05 (sham vs. OVX), dagger P<0.05 (sham(+/+) vs. sham (-/-)).
###end p 100
###begin p 101
(0.16 MB TIF)
###end p 101
###begin p 102
Click here for additional data file.
###end p 102
###begin p 103
We thank Professors Laurie K. McCauley (University of Michigan Ann Arbor) and Chuanyue Wu (University of Pittsburgh) for critical reading of this manuscript. Thanks to Dr. Sengyong Yang of University of Pittsburgh for assistance of EMSA. Thanks to Dr. Deborah L. Galson of University of Pittsburgh for valuable suggestions and discussion.
###end p 103
###begin title 104
References
###end title 104
###begin article-title 105
###xml 93 98 <span type="species:ncbi:9606">women</span>
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
###end article-title 105
###begin article-title 106
Parathyroid hormone is essential for normal fetal bone formation.
###end article-title 106
###begin article-title 107
Anabolic actions of parathyroid hormone during bone growth are dependent on c-fos.
###end article-title 107
###begin article-title 108
###xml 102 106 <span type="species:ncbi:10090">mice</span>
Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice.
###end article-title 108
###begin article-title 109
###xml 34 39 <span type="species:ncbi:9606">human</span>
###xml 175 179 <span type="species:ncbi:10090">mice</span>
Short-term continuous infusion of human parathyroid hormone 1-34 fragment is catabolic with decreased trabecular connectivity density accompanied by hypercalcemia in C57BL/J6 mice.
###end article-title 109
###begin article-title 110
Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone.
###end article-title 110
###begin article-title 111
###xml 71 75 <span type="species:ncbi:10090">mice</span>
Evidence that anabolic effects of PTH on bone require IGF-I in growing mice.
###end article-title 111
###begin article-title 112
###xml 78 82 <span type="species:ncbi:10090">mice</span>
Impaired bone anabolic response to parathyroid hormone in Fgf2-/- and Fgf2+/- mice.
###end article-title 112
###begin article-title 113
###xml 77 80 <span type="species:ncbi:10116">rat</span>
Functional properties of hormonally responsive cultured normal and malignant rat osteoblastic cells.
###end article-title 113
###begin article-title 114
Effects of differentiation and transforming growth factor beta 1 on PTH/PTHrP receptor mRNA levels in MC3T3-E1 cells.
###end article-title 114
###begin article-title 115
Parathyroid hormone-dependent signaling pathways regulating genes in bone cells.
###end article-title 115
###begin article-title 116
Induction of osteoblast differentiation indexes by PTHrP in MG-63 cells involves multiple signaling pathways.
###end article-title 116
###begin article-title 117
###xml 75 78 <span type="species:ncbi:10116">rat</span>
Stimulation of extracellular signal-regulated kinases and proliferation in rat osteoblastic cells by parathyroid hormone is protein kinase C- dependent.
###end article-title 117
###begin article-title 118
Osteoblastic cells regulate the haematopoietic stem cell niche.
###end article-title 118
###begin article-title 119
Cyclin D1 as a Target for the Proliferative Effects of PTH and PTHrP in Early Osteoblastic Cells.
###end article-title 119
###begin article-title 120
Proteasomal Degradation of Runx2 Shortens Parathyroid Hormone-induced Anti-apoptotic Signaling in Osteoblasts: A PUTATIVE EXPLANATION FOR WHY INTERMITTENT ADMINISTRATION IS NEEDED FOR BONE ANABOLISM.
###end article-title 120
###begin article-title 121
Parathyroid hormone and parathyroid hormone-related protein exert both pro- and anti-apoptotic effects in mesenchymal cells.
###end article-title 121
###begin article-title 122
Parathyroid hormone induces c-fos promoter activity in osteoblastic cells through phosphorylated cAMP response element (CRE)-binding protein binding to the major CRE.
###end article-title 122
###begin article-title 123
Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133.
###end article-title 123
###begin article-title 124
###xml 34 37 <span type="species:ncbi:10116">rat</span>
Parathyroid hormone regulates the rat collagenase-3 promoter in osteoblastic cells through the cooperative interaction of the activator protein-1 site and the runt domain binding sequence.
###end article-title 124
###begin article-title 125
Proto-oncogene c-fos is transcriptionally regulated by parathyroid hormone (PTH) and PTH-related protein in a cyclic adenosine monophosphate-dependent manner in osteoblastic cells.
###end article-title 125
###begin article-title 126
Parathyroid hormone stimulates fra-2 expression in osteoblastic cells in vitro and in vivo.
###end article-title 126
###begin article-title 127
Parathyroid hormone bone anabolic action requires cbfa1/runx2-dependent signaling.
###end article-title 127
###begin article-title 128
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene.
###end article-title 128
###begin article-title 129
Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation [see comments].
###end article-title 129
###begin article-title 130
ATF4 Is a Substrate of RSK2 and an Essential Regulator of Osteoblast Biology; Implication for Coffin-Lowry Syndrome.
###end article-title 130
###begin article-title 131
An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene.
###end article-title 131
###begin article-title 132
Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex.
###end article-title 132
###begin article-title 133
###xml 167 170 <span type="species:ncbi:10116">rat</span>
Synergistic induction of osteocalcin gene expression: identification of a bipartite element conferring fibroblast growth factor 2 and cyclic AMP responsiveness in the rat osteocalcin promoter.
###end article-title 133
###begin article-title 134
###xml 45 48 <span type="species:ncbi:10116">rat</span>
Parathyroid hormone (PTH 1-34) regulation of rat osteocalcin gene transcription [see comments].
###end article-title 134
###begin article-title 135
Parathyroid Hormone Induction of the Osteocalcin Gene: REQUIREMENT FOR AN OSTEOBLAST-SPECIFIC ELEMENT 1 SEQUENCE IN THE PROMOTER AND INVOLVEMENT OF MULTIPLE SIGNALING PATHWAYS.
###end article-title 135
###begin article-title 136
ATF4, the osteoblast accumulation of which is determined post-translationally, can induce osteoblast-specific gene expression in non-osteoblastic cells.
###end article-title 136
###begin article-title 137
Activating transcription factor 4 is critical for proliferation and survival in primary bone marrow stromal cells and calvarial osteoblasts.
###end article-title 137
###begin article-title 138
Parathyroid hormone increases activating transcription factor 4 expression and activity in osteoblasts: requirement for osteocalcin gene expression.
###end article-title 138
###begin article-title 139
The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation.
###end article-title 139
###begin article-title 140
Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development [see comments].
###end article-title 140
###begin article-title 141
Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia [see comments].
###end article-title 141
###begin article-title 142
Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts [see comments].
###end article-title 142
###begin article-title 143
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 91 95 <span type="species:ncbi:10116">rats</span>
Human parathyroid hormone-(1-34) increases bone mass in ovariectomized and orchidectomized rats.
###end article-title 143
###begin article-title 144
###xml 79 84 <span type="species:ncbi:10090">mouse</span>
Skeletal unloading alleviates the anabolic action of intermittent PTH(1-34) in mouse tibia in association with inhibition of PTH-induced increase in c-fos mRNA in bone marrow cells.
###end article-title 144
###begin article-title 145
Parathyroid hormone activates mitogen-activated protein kinase in opossum kidney cells.
###end article-title 145
###begin article-title 146
Anabolic actions of parathyroid hormone on bone.
###end article-title 146
###begin article-title 147
Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone.
###end article-title 147
###begin article-title 148
###xml 137 140 <span type="species:ncbi:10116">rat</span>
The anabolic effects of parathyroid hormone on cortical bone mass, dimensions and strength-assessed in a sexually mature, ovariectomized rat model.
###end article-title 148
###begin article-title 149
Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34.
###end article-title 149
###begin article-title 150
3',5'-Cyclic adenosine monophosphate activation in osteoblastic cells: effects on parathyroid hormone-1 receptors and osteoblastic differentiation in vitro.
###end article-title 150
###begin article-title 151
Molecular and cellular mechanisms of the anabolic effect of intermittent PTH.
###end article-title 151
###begin article-title 152
Impact of the mitogen-activated protein kinase pathway on parathyroid hormone-related protein actions in osteoblasts.
###end article-title 152
###begin article-title 153
Targeted disruption of ATF4 discloses its essential role in the formation of eye lens fibres.
###end article-title 153
###begin article-title 154
###xml 82 86 <span type="species:ncbi:10090">mice</span>
Microphthalmia due to p53-mediated apoptosis of anterior lens epithelial cells in mice lacking the CREB-2 transcription factor.
###end article-title 154
###begin article-title 155
Comparison of the action of transient and continuous PTH on primary osteoblast cultures expressing differentiation stage-specific GFP.
###end article-title 155
###begin article-title 156
###xml 204 208 <span type="species:ncbi:10116">rats</span>
Intermittent parathyroid hormone treatment increases osteoblast number, steady state messenger ribonucleic acid levels for osteocalcin, and bone formation in tibial metaphysis of hypophysectomized female rats.
###end article-title 156
###begin article-title 157
###xml 19 24 <span type="species:ncbi:9606">human</span>
Teriparatide (1-34 human PTH) regulation of osterix during fracture repair.
###end article-title 157
###begin article-title 158
Activation of osteocalcin transcription involves interaction of protein kinase A- and protein kinase C-dependent pathways.
###end article-title 158
###begin article-title 159
###xml 162 165 <span type="species:ncbi:10116">rat</span>
Parathyroid hormone regulation of bone sialoprotein (BSP) gene transcription is mediated through a pituitary-specific transcription factor-1 (Pit-1) motif in the rat BSP gene promoter.
###end article-title 159
###begin article-title 160
Parathyroid hormone regulates osterix and Runx2 mRNA expression predominantly through protein kinase A signaling in osteoblast-like cells.
###end article-title 160
###begin article-title 161
Multiple mechanisms are involved in inhibition of osteoblast differentiation by PTHrP and PTH in KS483 Cells.
###end article-title 161
###begin article-title 162
Role of Cbfa1 in osteoblast differentiation and function.
###end article-title 162
###begin article-title 163
Cooperative Interactions between Activating Transcription Factor 4 and Runx2/Cbfa1 Stimulate Osteoblast-specific Osteocalcin Gene Expression.
###end article-title 163
###begin article-title 164
###xml 19 23 <span type="species:ncbi:10090">mice</span>
CREM deficiency in mice alters the response of bone to intermittent parathyroid hormone treatment.
###end article-title 164
###begin article-title 165
SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation.
###end article-title 165
###begin article-title 166
General transcription factor IIA-gamma increases osteoblast-specific osteocalcin gene expression via activating transcription factor 4 and runt-related transcription factor 2.
###end article-title 166
###begin article-title 167
CCAAT/Enhancer-binding Protein {beta} Promotes Osteoblast Differentiation by Enhancing Runx2 Activity with ATF4.
###end article-title 167
###begin article-title 168
Physical interaction of the activator protein-1 factors, c-Fos and c- Jun, with Cbfa1 for collagenase-3 promoter activation.
###end article-title 168
###begin article-title 169
AP-1 and Cbfa/runt physically interact and regulate parathyroid hormone- dependent MMP13 expression in osteoblasts through a new osteoblast- specific element 2/AP-1 composite element.
###end article-title 169
###begin article-title 170
Parathyroid hormone signaling through low-density lipoprotein-related protein 6.
###end article-title 170
###begin article-title 171
Leptin regulation of bone resorption by the sympathetic nervous system and CART.
###end article-title 171
###begin article-title 172
Inhibition of Wnt signaling by the osteoblast-specific transcription factor Osterix.
###end article-title 172
###begin article-title 173
ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae.
###end article-title 173
###begin article-title 174
Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee.
###end article-title 174
###begin article-title 175
Osteocyte and osteoblast apoptosis and excessive bone deposition accompany failure of collagenase cleavage of collagen.
###end article-title 175
###begin article-title 176
A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development.
###end article-title 176
###begin article-title 177
Ascorbic acid-dependent activation of the osteocalcin promoter in MC3T3-E1 preosteoblasts: requirement for collagen matrix synthesis and the presence of an intact OSE2 sequence.
###end article-title 177
###begin p 178
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 178
###begin p 179
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by a NIH Grant DK072230 and a Department of Defense Grant W81XWH-07-1-0160 (to GX). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 179

